mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.11 |
0.09 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.09 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.071 |
0.09 |